Neurobiology, Neurodegeneration and Repair Laboratory (NNRL), National Eye Institute, Bethesda, MD 20892, USA.
Department of Ophthalmology, Baylor College of Medicine, Houston, TX 77030, USA.
Hum Mol Genet. 2020 Jul 29;29(12):2022-2034. doi: 10.1093/hmg/ddaa057.
Genome-wide association studies (GWAS) have identified 52 independent variants at 34 genetic loci that are associated with age-related macular degeneration (AMD), the most common cause of incurable vision loss in the elderly worldwide. However, causal genes at the majority of these loci remain unknown. In this study, we performed whole exome sequencing of 264 individuals from 63 multiplex families with AMD and analyzed the data for rare protein-altering variants in candidate target genes at AMD-associated loci. Rare coding variants were identified in the CFH, PUS7, RXFP2, PHF12 and TACC2 genes in three or more families. In addition, we detected rare coding variants in the C9, SPEF2 and BCAR1 genes, which were previously suggested as likely causative genes at respective AMD susceptibility loci. Identification of rare variants in the CFH and C9 genes in our study validated previous reports of rare variants in complement pathway genes in AMD. We then extended our exome-wide analysis and identified rare protein-altering variants in 13 genes outside the AMD-GWAS loci in three or more families. Two of these genes, SCN10A and KIR2DL4, are of interest because variants in these genes also showed association with AMD in case-control cohorts, albeit not at the level of genome-wide significance. Our study presents the first large-scale, exome-wide analysis of rare variants in AMD. Further independent replications and molecular investigation of candidate target genes, reported here, would assist in gaining novel insights into mechanisms underlying AMD pathogenesis.
全基因组关联研究(GWAS)已经在 34 个遗传位点上确定了 52 个与年龄相关性黄斑变性(AMD)相关的独立变异,AMD 是全球老年人不可治愈的视力丧失的最常见原因。然而,这些大多数位点的致病基因仍然未知。在这项研究中,我们对 63 个 AMD 多基因家族的 264 名个体进行了外显子组测序,并对 AMD 相关位点候选靶基因中的罕见蛋白改变变异进行了数据分析。在 3 个或更多家族中,CFH、PUS7、RXFP2、PHF12 和 TACC2 基因中发现了罕见的编码变异。此外,我们还检测到了 C9、SPEF2 和 BCAR1 基因中的罕见编码变异,这些基因先前被认为是各自 AMD 易感位点的可能致病基因。我们在 CFH 和 C9 基因中发现罕见变异,验证了先前关于 AMD 补体途径基因中罕见变异的报道。然后,我们扩展了我们的外显子组分析,并在 3 个或更多家族中发现了 13 个 AMD-GWAS 位点以外的基因中的罕见蛋白改变变异。其中两个基因 SCN10A 和 KIR2DL4 引起了我们的兴趣,因为这些基因的变异也与病例对照队列中的 AMD 相关,尽管没有达到全基因组显著性水平。我们的研究首次对 AMD 中的罕见变异进行了大规模的外显子组分析。对候选靶基因的进一步独立复制和分子研究,如本研究中报道的那样,将有助于深入了解 AMD 发病机制的潜在机制。